What medications are effective for treating sea sickness (motion sickness)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medication for Sea Sickness

Transdermal scopolamine is the most effective medication for preventing sea sickness, providing a 75% reduction in motion-induced nausea and vomiting when applied 4-16 hours before travel. 1

First-Line Recommendation: Transdermal Scopolamine

Apply the scopolamine transdermal patch to the hairless area behind one ear 4-16 hours before anticipated motion exposure. 1 The patch delivers approximately 1 mg of scopolamine over 3 days, with peak plasma concentrations reached within 24 hours of application. 1

Clinical Efficacy

  • In studies conducted at sea with 195 adult subjects, transdermal scopolamine demonstrated a 75% reduction in motion-induced nausea and vomiting. 1
  • A 3-day sailing study showed protection rates of 74%, 73%, and 39% on successive days, with no significant side effects compared to placebo. 2
  • When compared directly to oral dimenhydrinate and placebo at sea, transdermal scopolamine was significantly more effective (p = 0.0001) than placebo. 3

Administration Details

  • Only wear one patch at a time; do not cut the patch. 1
  • Apply to clean, dry, hairless skin behind the ear. 1
  • Wash hands thoroughly with soap and water immediately after handling to avoid accidental eye contact. 1
  • If the patch becomes displaced, discard it and apply a new one behind the other ear. 1
  • After removal, fold the used patch in half (sticky sides together) and dispose in household trash away from children and pets. 1

Side Effects

  • Minimal dry mouth, drowsiness, and blurred vision were reported with transdermal scopolamine. 3
  • The patch acts centrally by blocking cholinergic transmission from vestibular nuclei to higher CNS centers. 1

Alternative: First-Generation Antihistamines

If scopolamine is contraindicated or unavailable, first-generation antihistamines (cinnarizine or dimenhydrinate) are probably effective alternatives, preventing symptoms in approximately 40% of susceptible individuals compared to 25% with placebo. 4

Antihistamine Options

  • Cinnarizine, dimenhydrinate, cyclizine, or meclozine can be used for prevention. 5, 4
  • A comparative study of seven agents found that cinnarizine, cinnarizine with domperidone, cyclizine, dimenhydrinate with caffeine, and meclozine with caffeine all showed similar efficacy (4.1-10.2% experienced vomiting; 16.4-23.5% experienced malaise). 5
  • Scopolamine transdermal system was slightly less effective in this head-to-head comparison and caused more visual problems. 5

Important Caveat

  • Antihistamines may be more likely to cause sedation compared to placebo (66% vs 44%), which could impair performance during sailing. 4
  • They may result in little or no difference in blurred vision (14% vs 12.5%) or impaired cognition (29% vs 33%) compared to placebo. 4

What NOT to Use

Ondansetron (a 5-HT3 blocker) is not effective for sea sickness prevention. 6 A double-blind study of 16 volunteers at sea found no statistically significant reduction in seasickness symptoms with ondansetron 8 mg compared to placebo (Wiker score 2.69 vs 2.81). 6 The mechanism of nausea in motion sickness appears different from toxin-induced nausea, where 5-HT3 blockers are effective. 6

Practical Algorithm

  1. For most adults planning sea travel: Apply transdermal scopolamine patch 4-16 hours before departure. 1

  2. If scopolamine is contraindicated (e.g., glaucoma, urinary retention) or causes intolerable side effects: Use first-generation antihistamines such as dimenhydrinate or meclozine starting 1-2 hours before travel. 5, 4

  3. Avoid ondansetron as it has not demonstrated efficacy for motion sickness. 6

  4. Monitor for side effects: Wash hands after patch application to prevent accidental eye contamination, which can cause pupil dilation and visual disturbances. 1

References

Research

Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.

Aviation, space, and environmental medicine, 1987

Research

Transdermal scopolamine in the prevention of motion sickness at sea.

Clinical pharmacology and therapeutics, 1981

Research

Antihistamines for motion sickness.

The Cochrane database of systematic reviews, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.